Adult vaccine checks start with records, risk and local schedules

The World Health Organization (WHO) published an updated COVID-19 vaccine position paper on July 31, 2026. Its risk-based recommendations are one part of a broader adult vaccine review that also depends on past doses, age, pregnancy, health conditions, work and travel.

WHO's current summary tables cover children, adolescents and adults, but they are designed for national program decisions and not direct clinical use. A threshold or schedule published in one country therefore cannot be treated as a worldwide rule.

Breathing problems after a dose need emergency care

WHO says vaccine side effects are usually minor and short-lived, such as a sore arm or mild fever, while serious reactions are extremely rare. An unexpected reaction after vaccination warrants contact with a health professional.

The US Centers for Disease Control and Prevention lists generalized hives, throat swelling, wheezing, low blood pressure and shock among signs of an acute allergic reaction that can begin within minutes of vaccination. Breathing difficulty, collapse or rapidly worsening symptoms require immediate contact with local emergency services.

Start with the record, not a list of ages

The reason for another vaccine dose is not the same in every case. Some adults missed part of a primary series, some vaccines require periodic renewal, and a change in age, pregnancy, health, occupation or travel can create a new recommendation.

WHO treats catch-up vaccination as a routine part of immunization programs so people who missed scheduled doses can be identified and vaccinated at the earliest opportunity. A review begins with records from previous clinics or immunization systems, then applies the catch-up rules in the country where care is received.

Unknown history does not show that every childhood vaccine must be repeated. The local service needs to decide what documentation counts and whether the next step is a catch-up dose, a complete series, no action or further assessment.

Influenza and COVID-19 follow changing risks

WHO continues to recommend annual influenza vaccination before the influenza season and asks countries to prioritize health workers, older adults, pregnant people and those with underlying conditions. Season dates, eligible groups and publicly funded access differ among countries.

WHO's March 2026 COVID-19 advice asks countries to focus routine vaccination on the oldest adults, older adults with major comorbidities or severe obesity, long-term-care residents and moderately or severely immunocompromised people. Countries set the older-age cutoffs and may add other groups according to local conditions and feasibility.

Neither recommendation means every adult follows the same timetable. WHO says an inactivated seasonal influenza vaccine and a COVID-19 vaccine may be given during the same visit, while other combinations and intervals depend on the vaccines and local guidance.

Catch-up decisions depend on what was missed

WHO recommends measles vaccination for susceptible adults unless vaccination is contraindicated. National guidance determines which records or other evidence establish immunity and who should receive catch-up vaccination.

WHO says long-term tetanus protection comes from six tetanus-toxoid-containing doses across the life course. Adults who did not complete or cannot document the series need the applicable catch-up policy, rather than assuming that one booster interval applies in every country.

WHO makes girls aged nine to 14 the primary target for human papillomavirus (HPV) vaccination and says countries may extend vaccination to older females, boys and men where feasible and affordable. Adult age limits, authorization and public coverage must be checked for the country where vaccination would occur.

Older age does not produce one worldwide checklist

WHO recommends that countries consider recombinant shingles vaccination for older adults and people with chronic conditions where shingles is an important public health problem. The age threshold and access rules remain national decisions; a separate APPI News guide explains the evidence and the two-dose schedule.

WHO's 2021 note on pneumococcal vaccination in older adults found an inadequate evidence base, especially in low- and middle-income countries, for a single policy recommendation. A national program may use age, medical risk or both, so age 65 is not a universal eligibility rule.

Pregnancy and immune conditions need a separate review

Pregnancy changes which vaccines are recommended and when they are given. WHO includes pregnant people among its influenza priority groups, and its March 2026 COVID-19 guidance recommends vaccination during each pregnancy, but the locally available products and schedule still govern care.

WHO says immune-affecting illnesses and treatments can mean that a person should not receive a particular vaccine or should wait. The general age examples in this guide cannot replace a vaccine-specific plan from a clinician who knows the condition and treatment schedule.

Children are outside the scope of this adult guide. Pediatric schedules and catch-up intervals are separate and should not be inferred from adult examples.

Travel and work can add another layer

WHO advises an overseas traveler to review routine vaccination and check destination-specific recommendations or entry requirements with a health practitioner before departure. The destination, length and type of trip can change which selective travel vaccines are relevant.

Occupation can also alter exposure risk, and WHO maintains a separate vaccination recommendation table for health workers. Employers, occupational health services and national authorities set the rules that apply to a particular workplace.

A vaccine review can be planned in stages

Useful information for an appointment includes vaccination records, previous severe reactions, pregnancy status, chronic conditions, medicines that affect immunity, work exposures and planned travel. The vaccinating service can then separate doses due now from those that are optional, contraindicated, unavailable or scheduled later.

Cost and access require a separate check because regulatory authorization does not guarantee public funding or insurance coverage. The final record should show the vaccine and date received, with any next appointment recorded under the local schedule.

Frequently asked questions

Do all adults need the same vaccines?
No. Previous doses, age, pregnancy, health conditions, work, travel and the national schedule all affect which vaccines are indicated.

Does every childhood vaccine wear off?
No. WHO says protection after vaccination can last for years, decades or a lifetime; other schedules involve catch-up or boosters, while influenza and COVID-19 address changing or waning protection.

Is age 50 or 65 a worldwide vaccination cutoff?
No. Countries choose age and risk thresholds, and WHO has not set one universal older-adult schedule for shingles or pneumococcal vaccination.

Must several indicated vaccines be given on different days?
Not always. WHO accepts giving inactivated seasonal influenza and COVID-19 vaccines at the same visit, but other combinations follow local and product-specific guidance.

What happens when vaccination records are missing?
The applicable local catch-up policy determines what evidence is accepted and which doses are needed. Missing documentation alone does not establish that every series must start again.